Koyfin Home > Directory > Health Care > Aimmune Therap > Total Assets

Aimmune Therap Total Assets Chart (AIMT)

Aimmune Therap annual/quarterly Total Assets from 2014 to 2020.
  • Aimmune Therap Total Assets for the quarter ending June 06, 2020 was $365m a 32.00% increase of 117m year over year
  • Aimmune Therap Total Assets for the last 12 months ending June 06, 2020 was $365m a 32.00% increase of 117m year over year
  • Aimmune Therap Annual Total Assets for 2019 was $204m a -66.15% decrease of -135m from 2018
  • Aimmune Therap Annual Total Assets for 2018 was $340m a 39.06% increase of 133m from 2017
  • Aimmune Therap Annual Total Assets for 2017 was $207m a -44.39% decrease of -92m from 2016
Other Balance Sheet Metrics:
  • Aimmune Therap Other Liabilities for the quarter ending December 12, 2018 was $3m a 9.82% increase of 0m year over year
  • Aimmune Therap Total Equity for the quarter ending September 09, 2018 was $247m a 28.06% increase of 69m year over year
View Chart On Koyfin

Quarterly AIMT Total Assets Data

06/2020$365m
03/2020$420m
12/2019$204m
09/2019$248m
06/2019$299m
03/2019$344m
12/2018$340m
09/2018$287m
06/2018$327m
03/2018$362m

Annual AIMT Total Assets Data

2019$204m
2018$340m
2017$207m
2016$299m
2015$212m
2014$3m
2013$12m